Hematology
Reading List
Malignant Hematologic Disorders
1. Pui CH ET. et al. Acute Lymphoblastic Leukemia. NEJM 2004; 350: 15351548.
2. Kralovics R. et. al. A Gain of Function Mutation of JAK2 in Myeloproliferative
Disorders. NEJM 2005; 352: 1779-90.
3. Talpaz M., et.al. Dasatinib in Imatinib-Resistant Philadelphia ChromosomePositive Leukemia. NEJM (2006) 354:2351-2341.
4. List A. et. al. Efficacy of Lenalidomide in Myelodysplastic Syndromes. NEJM
2005: 352:549-557.
5. Davidson MB, et al. Pathophysiology, Clinical Consequences and Treatment of
Tumor Lysis Syndrome. Am J Med. 2004;116:546-554.
6. Copelan E. Hematapoietic Stem Cell Transplant. NEJM 2006; 354:1813-26.
7. Chiorazzi N, et. al. Chronic Lymphocytic Leukemia. NEJM 2005; 352:804-12.
8. Kyle RA, Multiple Myeloma NEJM. 2004;351:1860-1872.
9. Blum KA. et al. Adult Burkitt Leukemia and Lymphoma. Blood 2004: 104:
3009-3020.
10. Habermann TM. Rituximab-CHOP Versus CHOP Alone or With Maintenance
Rituximab in Older Patients With Diffuse Large B-Cell Lymphoma. J Clin Oncol
2006; 24:3121-312 .
Benign Hematologic Disorders
1. Hertzberg MS. Genetic Testing for Thrombophilia Mutations. Semin Thromb
Hemost. 2005;31:33-38.
2. George J. Thrombotic Thrombocytopenia Purpura, NEJM 2006; 354:1927-35.
3. Mannucci PM. et al. Recessively Inherited Hematologic Disorders. Blood.
2004;104:1243-1252.
4. Levi M. et. al. Review of pathogenesis, diagnosis, and management of DIC.
NEJM 1999;341:586-592.
5. Adams P, et. al. Hemachromatosis and Iron-Overload Screening in a Racially
Diverse Population. NEJM 2005; 352:1769-78.
6. Kaushansky K. Lineage Specific Hematapoietic Growth Factors. NEJM 2006;
354:2034-45.
7. Rund D. et. al. - Thalessemia. NEJM 2005; 351:1135-46.
8. Atweh GF. Et. al. Pharmacologic Induction of Fetal Hemoglobin: Raising the
therapeutic Bar in Sickle Cell Disease. Current Opinion in Hematology. 2001;
8:123-130.
9. Brodsky RA, et al. Aplastic Anemia. Lancet. 2005;365:1647-1656.
10. Warkentin TE et al. Heparin-induced thrombocytopenia: recognition, treatment,
and prevention: the seventh ACCP conference on antithrombotic and
thrombolytic therapy. Chest. 2005;126:311s-337s.
Selected Websites
1. American Society of Hematology www.hematology.org
2. American Society of Clinical Oncology www.nccn.org
3. International Society of Thrombosis and Haemostasis www.med.unc.edu/isth/
4. National Cancer Institute www.cancer.gov
5. National Comprehensive Cancer Network www.nccn.org
6. National Hemophilia Foundation www.hemophlia.org
7. OMIM, Online Mendelian Inheritance in Man www.ncbi.nlm.nih.gov/omim/
8. National Heart Lung Blood Institute www.nhlbi.nih.gov/